MedTrace Logo

SMART-IC-Pilot Study

NCT07336433 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2026-01-13

No results posted yet for this study

Summary

This small-scale, proof-of-concept pilot study aims to obtain preliminary evidence of msRDN procedural safety, feasibility, and short-term efficacy in patients with hypertension without medication therapy, to adequately plan an appropriate pivotal study.

Conditions

  • Hypertensive Disease

Interventions

DEVICE

The SymPioneer G2 Mapping/Selective Renal Denervation Device and SyMapCath Catheter II

Radiofrequency ablation of renal arterial sympathetic nerves

Sponsors & Collaborators

  • SyMap Medical (Suzhou), Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2027-06-30
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07336433 on ClinicalTrials.gov